When: Thursday 16 December 2021
What time: 7 – 8pm GMT
Where: Online (Zoom Webinar)

Join us this festive season to gain a deeper understanding of the big questions being answered by dementia research. Our Chief Medical Officer Prof Jon Schott, will be joined by Dr Gargi Banerjee and Dr Federica Marinaro, with the discussion chaired by our CEO, Hilary Evans.

In their conversation, they will explore topics like using digital technology to detect dementia earlier, improving brain health and new treatments on the horizon. Come along to ask your questions and hear about the progress made in 2021.

Attendees will have the opportunity to submit questions, both ahead of the event and during it.

The event will take place online on Zoom, and it is free to attend. It is open to everyone, and no previous knowledge of dementia or research is required.


Jonathan Schott crop

Prof Jonathan Schott is the Chief Medical Officer of Alzheimer’s Research UK, providing clinical expertise to help drive forward our research priorities. He is Professor of Neurology at the Dementia Research Centre, UCL where he leads on a number of clinical research projects. Jon also runs a busy cognitive disorders service at National Hospital for Neurology and Neurosurgery, with a particular emphasis on young onset and rare dementias.

Gargi Banerjee

Dr Gargi Banerjee is a neurologist and Alzheimer’s Research UK Clinical Fellow based at UCL. She combines her work on hospital wards with people affected by neurological diseases (those involving the brain, spinal cord and nerves), with her research work investigating the causes of dementia and stroke. Her research focusses on cerebral amyloid angiopathy (CAA), in which deposits of amyloid protein build up in blood vessels in the brain. She is exploring how and why these deposits occur, to understand the link between CAA, Alzheimer's disease and vascular dementia.

Federica Marinaro

With over a decade of experience in neuroscience research, Dr Federica Marinaro now plays a key role in the Early Detection of Neurodegenerative Diseases (EDoN) initiative, leading the work on strategic collaborations. Spearheaded by Alzheimer’s Research UK, this initiative sets out to develop wearable technology to capture digital health data to detect diseases like Alzheimer’s years before the symptoms of dementia start.

Hilary headshot 3 December 2020

Hilary Evans has been Chief Executive of Alzheimer’s Research UK since 2015, and has led the transformation of the charity into one of the leading medical research charities in the UK. She has overseen significant growth in recent years, enhancing the organisation’s ability to fund ground-breaking innovative projects. She has also led major public campaigns aiming to shift public perceptions of dementia and break down stigma around these diseases. She is a trustee of the Association of Medical Research Charities and holds an honorary doctorate in medicine from The University of Exeter.

For more information or questions about the event, please email the Public Engagement team